Insider sale
WEREWOLF THERAPEUTICS, INC.
$123.8K
240.28K shares
What this filing means
UBS ONCOLOGY IMPACT FUND L.P. plans to sell 240.28K shares of WEREWOLF THERAPEUTICS, INC. valued at approximately $123.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/18/2026ACC: 0001628280-26-036035
10% Owner
Since Apr 2021
240.28K
Shares to sell
$123.8K
Approx. market value
240.28K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Private Placement
Cash
5/4/2021
240.28KTotal acquired240.28K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/4/2021 | Private Placement Cash | 240.28K | — |
| Total | 240.28K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
240.28K
Market value
$123.8K
5/18/2026
Total
Units
240.28K
Value
$123.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
5/18/2026 | 240.28K | $123.8K | NASDAQ | Planned |
| Total | 240.28K | $123.8K | ||